Letter to the EditorImpact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia
References (18)
- et al.
Mortality of Staphylococcus aureus bacteremia and infectious diseases specialist consultation – a study of 521 patients in Germany
J Infect
(2009) - et al.
The value of infectious diseases consultation in Staphylococcus aureus bacteremia
Am J Med
(2010) - et al.
Course and outcome of Staphylococcus aureus bacteremia: a retrospective analysis of 308 patients in a Swiss tertiary-care centre
Clin Microbiol Infect
(2006) - et al.
The ACCP-SCCM consensus conference on sepsis and organ failure
Chest
(1992) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia
J Infect
(2009) - et al.
Staphylococcus aureus endocarditis: a consequence of medical progress
JAMA
(2005) - et al.
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance
Medicine (Baltimore)
(2003) - et al.
Clinical identifiers of complicated Staphylococcus aureus bacteremia
Arch Intern Med
(2003)
Cited by (27)
Nanofiber films based on anthocyanins for quantitative detection of pathogenic bacteria
2024, Materials Today SustainabilityImpact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management
2021, Diagnostic Microbiology and Infectious DiseaseInfectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis
2016, Journal of InfectionCitation Excerpt :Only two studies were multicentric.16,22 Most studies were not limited to one department, but were conducted throughout the hospital including intensive care units and general wards of primary, secondary, and tertiary care hospitals in North America,22,26,27,29,31,33 Europe,16,23,25,28,30,34,36–38 Asia24,28,32 and Australia.35 The number of enrolled patients ranged from 59 to 847 and the study period from 12 to 120 months.
The impact of infectious disease specialists on antibiotic prescribing in hospitals
2014, Clinical Microbiology and InfectionCitation Excerpt :As seven of 31 studies had a design that complied with the Cochrane Effective Practice and Organization of Care Group recommendations (randomized controlled trial, before/after controlled study, or before/after uncontrolled study with interrupted time-series analysis; available at http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf), the quality of evidence can be categorized as moderately high. Beyond the impact of IDSs on antibiotic use, several studies also showed that IDS intervention was associated with reduced length of stay [22,36,42], decreased mortality [22,52–54,56,57], a reduction in the prevalence of multiresistant bacteria [41,58], and a reduction in the overall costs of antibiotics [36,41,45,47,48,58]. This cost-saving impact was particularly important when IDSs were totally responsible for the prescriptions of antibiotics [36], and was shown to compensate for the annual salary of the IDS [41,48]; however, it is important to recognize that the majority of antibiotics prescribed are increasingly generics, so the impact on cost is likely to be lower in clinical practice than seen in studies over the past two decades.
Clinical and microbiological characteristics of Staphylococcus lugdunensis
2022, Current Opinion in Infectious Diseases